Dr. Azra Raza's approach to research seeks to prevent the first cancer cell instead of trying to eliminate the last.
The Faculty Ambassador program helps faculty connect with CTV and with one another around innovation and commercialization.
Part of Columbia Technology Ventures, the Carbontech Development Initiative is pleased to announce awards of over $2.6 million to research and commercialization teams working to develop and scale critical carbon-related technologies.
A phase 3 trial of Belite Bio’s Tinlarebant in adolescents with a rare genetic eye disease has met its primary endpoint! The company plans to seek FDA approval in the first half of next year. The startup is based on discoveries by Columbia's Dr. Konstantin Petrukhin.
Based out of Columbia Technology Ventures, CDI is a carbontech market transformation and grant-seeding commercialization hub.
UCB received FDA approval for a TK2d nucleoside therapy developed by Columbia's Dr. Michio Hirano.
At Columbia Engineering, Dr. Dan Esposito and his team are developing an alternative to Nafion. Their work, in collaboration with industrial partners Nel Hydrogen and Forge Nano, aims to replace the Nafion membranes used in conventional electrolyzers with ultra-thin, PFAS-free oxide membranes. Replacing this component eliminates upwards of 99% of the PFAS contained in an electrolyzer.
Leaders from the Herbert Irving Comprehensive Cancer Center (HICCC) and Columbia Technology Ventures visited JLABS on Aug. 27 to share how Columbia University’s cutting-edge medical and scientific research infrastructure can help startups translate discoveries into patient impact.
Dr. Kristin Myers is developing advanced tools to help doctors better predict and prevent serious pregnancy complications, like preterm birth.
Dr. Shree Nayar's lab revolutionized digital photography with a new kind of imaging now used in more than a billion smartphones.
The STAR (Sperm Tracking and Recovery) system, developed by Columbia's Dr. Zev Williams, was named one of TIME's Best Inventions of 2025.
The startup was founded by Columbia's Dr. Charles Zuker.